Cyclerion Therapeutics In...

NASDAQ: CYCN · Real-Time Price · USD
2.39
0.06 (2.58%)
At close: Aug 15, 2025, 3:59 PM
2.39
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Cyclerion Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2M n/a 297K 3.32M
Cost of Revenue
n/a n/a 65K 472K
Gross Profit
2M n/a 232K 2.85M
Operating Income
-3.63M -9.65M -44.37M -55.2M
Interest Income
208K 358K 294K n/a
Pretax Income
-3.06M -12.59M -44.08M -51.65M
Net Income
-3.06M -21.02M -43.78M -51.66M
Selling & General & Admin
5.34M 8.13M 14.5M 20.62M
Research & Development
286K 1.51M 31.49M 37.64M
Other Expenses
n/a n/a -1.33M -622K
Operating Expenses
5.63M 9.65M 44.67M 57.63M
Interest Expense
n/a n/a 294K 16K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
5.63M 9.65M 44.67M 57.63M
Income Tax Expense
n/a n/a -294K 16K
Shares Outstanding (Basic)
2.52M 2.34M 2.17M 1.96M
Shares Outstanding (Diluted)
2.52M 2.34M 2.17M 1.96M
EPS (Basic)
-1.21 -8.99 -20.15 -26.4
EPS (Diluted)
-1.21 -8.99 -20.15 -26.4
EBITDA
-3.63M -12.59M -18.18M -55.2M
EBIT
-3.63M -12.59M -18.54M -54.31M
Depreciation & Amortization
n/a -2.95M 65K 472K